Tutto DSpace

Mostra i principali dati dell'item

Letter to the editor: The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in developing a COVID-19 comorbidity-based host risk score

dc.creatorVavougios G.D.en
dc.date.accessioned2023-01-31T10:30:17Z
dc.date.available2023-01-31T10:30:17Z
dc.date.issued2020
dc.identifier10.1186/s13054-020-02903-9
dc.identifier.issn13648535
dc.identifier.urihttp://hdl.handle.net/11615/80527
dc.description.abstract[No abstract available]en
dc.language.isoenen
dc.sourceCritical Careen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85084964787&doi=10.1186%2fs13054-020-02903-9&partnerID=40&md5=fcd54783ccc8be616a6208869bf76676
dc.subjectangiotensin 2 receptoren
dc.subjectangiotensin receptor antagonisten
dc.subjectdipeptidyl carboxypeptidase inhibitoren
dc.subjectmessenger RNAen
dc.subjectcomorbidityen
dc.subjectcoronavirus disease 2019en
dc.subjectdiabetes mellitusen
dc.subjectdrug effecten
dc.subjecthosten
dc.subjecthumanen
dc.subjecthyperglycemiaen
dc.subjecthypertensive patienten
dc.subjectLetteren
dc.subjectphenotypeen
dc.subjectpriority journalen
dc.subjectrisk factoren
dc.subjectscoring systemen
dc.subjectSevere acute respiratory syndrome coronavirus 2en
dc.subjectBetacoronavirusen
dc.subjectcomorbidityen
dc.subjectCoronavirus infectionen
dc.subjectpandemicen
dc.subjectvirus pneumoniaen
dc.subjectAngiotensin Receptor Antagonistsen
dc.subjectAngiotensin-Converting Enzyme Inhibitorsen
dc.subjectBetacoronavirusen
dc.subjectComorbidityen
dc.subjectCoronavirus Infectionsen
dc.subjectPandemicsen
dc.subjectPneumonia, Viralen
dc.subjectBioMed Central Ltd.en
dc.titleLetter to the editor: The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in developing a COVID-19 comorbidity-based host risk scoreen
dc.typeotheren


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item